期刊
LANCET HAEMATOLOGY
卷 7, 期 8, 页码 E601-E612出版社
ELSEVIER SCI LTD
DOI: 10.1016/S2352-3026(20)30205-2
关键词
-
类别
资金
- National Cancer Institute
- National Cancer Institute of the National Institutes of Health [P30 CA016359]
- MRC [MC_UU_12009/11, G1000729, MR/L008963/1, MC_U137961146, MC_UU_00016/11] Funding Source: UKRI
The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global public health crisis. Multiple observations indicate poorer post-infection outcomes for patients with cancer than for the general population. Herein, we highlight the challenges in caring for patients with acute leukaemias and myeloid neoplasms amid the COVID-19 pandemic. We summarise key changes related to service allocation, clinical and supportive care, clinical trial participation, and ethical considerations regarding the use of lifesaving measures for these patients. We recognise that these recommendations might be more applicable to high-income countries and might not be generalisable because of regional differences in health-care infrastructure, individual circumstances, and a complex and highly fluid health-care environment. Despite these limitations, we aim to provide a general framework for the care of patients with acute leukaemias and myeloid neoplasms during the COVID-19 pandemic on the basis of recommendations from international experts.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据